94 related articles for article (PubMed ID: 2489324)
1. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases].
Shibasaki K; Soga K; Toshima M; Aikawa K; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K; Kato J
Shigaku; 1989 Oct; 77(3):1031-41. PubMed ID: 2489330
[TBL] [Abstract][Full Text] [Related]
3. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer].
Ogoshi K; Kondo Y; Akiba Y; Sugihara T; Ko S; Noto T; Makuuchi H; Tajima T; Mitomi T
Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of a serum immunosuppressive (IS) substance in various diseases].
Mannami T; Fuchimoto S; Amamiya S; Morioka S; Tanaka S; Tanaka N; Konaga E; Orita K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2104-12. PubMed ID: 6191693
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
12. [Clinical use of the serum level of immuno-suppressive acidic protein (IAP) in gastroenterological surgery].
Tada I; Okuma T; Hongo H; Sada E; Tashiro S; Miyauchi Y
Gan No Rinsho; 1983 Apr; 29(4):A-20, 315-20. PubMed ID: 6854966
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive substance in the sera of head and neck cancer patients.
Yamanaka N; Harabuchi Y; Himi T; Kataura A
Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
15. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
Higuchi Y
Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
17. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
19. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
20. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]